July 25 news, Zhejiang value of medical technology limited liability company (later referred to as "value of medical") completed tens of millions of yuan of A round of financing. This round of financing was led by Guangzhou SeeSu Capital and continuous investment, Hangzhou Westlake Science and Technology Venture Capital, Guangdong Juicheng Assets and other followers. The funding will be used for clinical research, product development and certification of smart wearable medical devices for idiopathic scoliosis, R&D and management talent development, as well as building flagship offline medical service centers in several central cities that are close to clinical needs.

Founded in October 2021, Valuable Healthcare's mission is to provide non-invasive treatment for idiopathic scoliosis, which is trending to become the third largest public health problem among adolescents globally, and to further improve the spinal health of the entire population. Currently, Value Medical has developed an innovative neuroscience and kinesiology-based treatment for idiopathic scoliosis - "Brain Learning Training Method (BLTM)". ".

This method is the world's first non-invasive conservative treatment for idiopathic scoliosis patients from the neural level of the brain rather than from the skeletal muscle level, i.e., based on the nerve center, reintegrate the process of "sensory input-central integration-functional output" of the brain center of patients with scoliosis, and adjust the processing of sensory input messages by patients' cerebral cortical areas correctly. It correctly adjusts the processing of sensory input messages in the patient's cerebral cortex, reduces or even eliminates the brain's localization error of spatial position, and thus realizes the patient's precise and effective rehabilitation of scoliosis.